586
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

Erratum

Page 503 | Published online: 12 Jul 2009
This article refers to:
Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression

Re: Darbinyan, V, Aslanyan, G, Amroyan, E, Gabrielyan, E, Malmström, C, Panossian, A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic Journal of Psychiatry, 2007; 61: 343–48.

Regrettably, mistakes occurred in this article. On page 345 on rows 8 and 25; it should read “HAMD and BDI” and below you can see the correct .

Table 3.  Total scores obtained by patients suffering from mild and moderate depression in treatment groups A and B (verum) and the placebo group C submitted to the Beck Depression Inventory (BDI) questionnaire prior to (day 0) and after (day 42) treatment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.